SKAN Group AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0013396012
CHF
48.40
-1.15 (-2.32%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Dec'16
Net Sales
276.95
235.97
191.69
3.76
2.85
1.95
15.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
276.95
235.97
191.69
3.76
2.85
1.95
15.40
Raw Material Cost
76.46
64.16
58.68
0.01
0.00
0.70
0.74
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
124.86
107.74
91.77
0.42
0.40
0.69
0.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.14
0.56
0.15
0.01
0.01
0.00
0.00
Selling and Distribution Expenses
27.39
25.97
19.09
0.46
0.38
0.16
0.50
Other Expenses
1.76
1.28
1.13
-1.51
-0.35
-1.48
-0.27
Total Expenditure (Excl Depreciation)
247.49
211.21
180.99
-14.20
-2.75
-13.25
-0.74
Operating Profit (PBDIT) excl Other Income
29.5
24.8
10.700000000000001
18
5.6000000000000005
15.2
16.1
Other Income
-3.08
0.91
1.67
0.00
0.00
0.00
-0.00
Operating Profit (PBDIT)
37.08
33.29
18.16
17.96
5.61
15.20
16.14
Interest
1.14
0.56
0.15
0.01
0.01
0.00
0.00
Exceptional Items
0.00
-1.50
-0.45
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
189.80
164.18
127.22
3.75
0.00
1.24
14.66
Depreciation
10.69
7.63
5.79
0.00
0.00
0.00
0.00
Profit Before Tax
25.24
23.60
11.78
17.96
5.59
15.20
16.14
Tax
3.79
3.33
1.97
0.00
-0.17
0.00
0.17
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.99
10.62
4.53
17.96
5.76
15.20
15.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.99
10.62
4.53
17.96
5.76
15.20
15.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.46
10.78
7.05
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
21.45
21.40
11.59
17.96
5.76
15.20
15.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.35
0.75
0.75
0.75
0.75
Reserves
157.30
159.75
41.65
111.93
93.89
86.57
71.17
Earnings per share (EPS)
0.84
0.84
0.43
1.72
0.56
1.48
1.56
Diluted Earnings per share
0.84
0.84
0.43
1.72
0.56
1.48
1.56
Operating Profit Margin (Excl OI)
10.64%
10.49%
5.58%
478.03%
196.41%
780.39%
104.78%
Gross Profit Margin
12.97%
13.23%
9.16%
477.85%
196.04%
780.61%
104.8%
PAT Margin
6.86%
4.5%
2.36%
477.85%
201.85%
780.39%
103.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2022 is 17.37% vs 23.11% in Dec 2021

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2022 is 0.00% vs 84.48% in Dec 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2022 is 24.07% vs 96.36% in Dec 2021

stock-summary

Interest

YoY Growth in year ended Dec 2022 is 83.33% vs 500.00% in Dec 2021

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2022 has improved from Dec 2021

Compare Annual Results Of SKAN Group AG With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
Net Sales
276.95
496.24
-219.29
-44.19%
Other Operating Income
0.00
0.00
0.00
Total Operating income
276.95
496.24
-219.29
-44.19%
Raw Material Cost
76.46
175.87
-99.41
-56.52%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
124.86
157.42
-32.56
-20.68%
Power Cost
0
0
0.00
Manufacturing Expenses
1.14
6.64
-5.50
-82.83%
Selling and Distribution Expenses
27.39
235.11
-207.72
-88.35%
Other Expenses
1.76
-15.34
17.10
111.47%
Total Expenditure (Excl Depreciation)
247.49
421.63
-174.14
-41.30%
Operating Profit (PBDIT) excl Other Income
29.46
74.61
-45.15
-60.51%
Other Income
-3.08
-9.17
6.09
66.41%
Operating Profit (PBDIT)
37.08
121.45
-84.37
-69.47%
Interest
1.14
6.64
-5.50
-82.83%
Exceptional Items
0.00
-1.75
1.75
100.00%
Gross Profit (PBDT)
189.80
320.38
-130.58
-40.76%
Depreciation
10.69
56.01
-45.32
-80.91%
Profit Before Tax
25.24
57.06
-31.82
-55.77%
Tax
3.79
11.04
-7.25
-65.67%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.99
46.01
-27.02
-58.73%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.99
46.01
-27.02
-58.73%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
2.46
0.00
2.46
Other related items
0.00
0.00
0.00
Consolidated Net Profit
21.45
46.01
-24.56
-53.38%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
157.30
306.85
-149.55
-48.74%
Earnings per share (EPS)
0.84
2.30
-1.46
-63.48%
Diluted Earnings per share
0.84
2.30
-1.46
-63.48%
Operating Profit Margin (Excl OI)
10.64%
15.04%
0.00
-4.40%
Gross Profit Margin
12.97%
22.78%
0.00
-9.81%
PAT Margin
6.86%
9.27%
0.00
-2.41%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.70 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 17.37% vs 23.11% in Dec 2021

Annual - Consolidate Net Profit
Consolidate Net Profit 2.14 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 0.00% vs 84.48% in Dec 2021

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.02 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 24.07% vs 96.36% in Dec 2021

Annual - Interest
Interest 0.11 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 83.33% vs 500.00% in Dec 2021

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.64%
in Dec 2022

Figures in %
stock-summary

YoY Growth in year ended Dec 2022 has improved from Dec 2021